Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep673 | Pituitary: basic and neuroendocrinology | ECE2015

Progressive reduction of tolvaptan doses in the treatment of chronic SIADH

Ruiz-Gracia Teresa , Ortola Ana , Crespo Irene , Santiago Alejando , Gomez-Hoyos Emilia , Recio Lourdes , Cuesta Martin , Paz Pacheco Maria , Calle-Pascual Alfonso , Runkle Isabelle

Introduction: Chronic tolvaptan (TV) therapy has been found to be safe and effective in the treatment of chronic SIADH. However, experience with modification of doses over time is limited.Methods: We conducted a retrospective analysis of weekly TV doses (mg) in 41 patients with chronic SIADH treated for a minimum of 3 months, seen a week following discharge and monthly thereafter. Serum sodium (SNa) goal was 137–140 mmol/l, with 50% TV dose reductio...

ea0056p1063 | Thyroid (non-cancer) | ECE2018

The accuracy of diagnostic tests in amiodarone-induced thyrotoxicosis; a case-series

Cuesta Martin , Ruiz Cristina Gonzalez , Varas Ines Jimenez , Lapena Luis , Ganado Tomas , Merino Salome , Santiago Alejandro , Recio Lourdes , Pascual Alfonso Luis Calle , Vega Isabelle Runkle de la

Introduction: Amiodarone-induced thyrotoxicosis (AIT) can present a high morbi-mortality.Initial subtype identification facilitates appropriate management.We describe the utility of diagnostic tests in a cohort of patients with AIT.Material and methods: Retrospective, observational study of 59 patients attended from 2007 to 2018 in outpatient clinic. Differential diagnosis: type I if FT4 and FT3 (TH) were normalized following therapy with antithyroid dru...